GlassScriptPhysician profile
George Hanna
NPI 1124027669
$41,446.92
in general payments reported to CMS, 2019-2025
32 companies · $418 in 2025
The $418 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $3,942 · 2021: $11K · 2022: $943 · 2023: $3,383 · 2024: $349 · 2025: $418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,400 · Food and Beverage: $1,670 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,400.00 |
| Food and Beverage | $1,670.11 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $34,015.76 | 2019-2024 | Cardiomems, Supera, Gallant |
| Biotronik INC. | $2,696.52 | 2021-2023 | |
| Amarin Pharma, INC. | $706.25 | 2019-2022 | |
| Amgen INC. | $606.14 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $462.16 | 2019-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $457.85 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $440.88 | 2019-2025 | |
| Cardiva Medical, INC. | $327.62 | 2022-2023 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 5f Vcs |
| Merck Sharp & Dohme LLC | $248.10 | 2021-2025 | Verquvo, Capvaxive, Belsomra |
| Janssen Pharmaceuticals, INC | $212.81 | 2020-2021 | |
| Pfizer INC. | $154.12 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $138.15 | 2020-2024 | Eliquis, Camzyos |
| Heartflow, INC. | $120.77 | 2022-2024 | |
| Kowa Pharmaceuticals America, INC. | $91.81 | 2019-2021 | |
| Boston Scientific Corporation | $89.18 | 2019-2025 | Watchman Flx, General - Stents |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $80.84 | 2023-2024 | Inpefa |
| Actelion Pharmaceuticals US, INC. | $79.99 | 2024 | Opsumit, Uptravi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $67.77 | 2021-2022 | |
| Scpharmaceuticals INC. | $66.75 | 2023-2025 | |
| Penumbra, INC. | $63.06 | 2023 | Indigo System |
| Edwards Lifesciences Corporation | $50.07 | 2025 | |
| Shockwave Medical, INC | $49.87 | 2022 | |
| Biosense Webster, INC. | $43.58 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $37.74 | 2022-2025 | Farxiga |
| Kiniksa Pharmaceuticals International, Plc | $27.21 | 2024 | Arcalyst |
| Abiomed | $25.59 | 2023 | Impella |
| Medtronic Vascular, INC. | $18.48 | 2019 | |
| Biomerieux INC | $17.00 | 2025 | Filmarray Torch Module |
| Esperion Therapeutics, INC. | $15.64 | 2022 | |
| Infobionic, INC | $15.03 | 2021 | |
| Arbor Pharmaceuticals, INC. | $14.10 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $6.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Hanna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.